{
    "title": "A hybrid quantum-classical fusion neural network to improve protein-ligand binding affinity predictions for drug discovery. (arXiv:2309.03919v1 [quant-ph])",
    "abstract": "The field of drug discovery hinges on the accurate prediction of binding affinity between prospective drug molecules and target proteins, especially when such proteins directly influence disease progression. However, estimating binding affinity demands significant financial and computational resources. While state-of-the-art methodologies employ classical machine learning (ML) techniques, emerging hybrid quantum machine learning (QML) models have shown promise for enhanced performance, owing to their inherent parallelism and capacity to manage exponential increases in data dimensionality. Despite these advances, existing models encounter issues related to convergence stability and prediction accuracy. This paper introduces a novel hybrid quantum-classical deep learning model tailored for binding affinity prediction in drug discovery. Specifically, the proposed model synergistically integrates 3D and spatial graph convolutional neural networks within an optimized quantum architecture. S",
    "link": "http://arxiv.org/abs/2309.03919",
    "context": "Title: A hybrid quantum-classical fusion neural network to improve protein-ligand binding affinity predictions for drug discovery. (arXiv:2309.03919v1 [quant-ph])\nAbstract: The field of drug discovery hinges on the accurate prediction of binding affinity between prospective drug molecules and target proteins, especially when such proteins directly influence disease progression. However, estimating binding affinity demands significant financial and computational resources. While state-of-the-art methodologies employ classical machine learning (ML) techniques, emerging hybrid quantum machine learning (QML) models have shown promise for enhanced performance, owing to their inherent parallelism and capacity to manage exponential increases in data dimensionality. Despite these advances, existing models encounter issues related to convergence stability and prediction accuracy. This paper introduces a novel hybrid quantum-classical deep learning model tailored for binding affinity prediction in drug discovery. Specifically, the proposed model synergistically integrates 3D and spatial graph convolutional neural networks within an optimized quantum architecture. S",
    "path": "papers/23/09/2309.03919.json",
    "total_tokens": 864,
    "translated_title": "一种用于药物发现的混合量子-经典融合神经网络以提高蛋白质-配体结合亲和力预测的准确性",
    "translated_abstract": "药物发现领域关键在于准确预测潜在药物分子与靶蛋白之间的结合亲和力，特别是当这些蛋白直接影响疾病的进展时。然而，估计结合亲和力需要显著的财务和计算资源。虽然最先进的方法使用经典机器学习技术，但新兴的混合量子机器学习模型显示出更好的性能，这归功于它们固有的并行性和管理数据维度指数级增加的能力。尽管有这些进展，现有模型在收敛稳定性和预测准确性方面存在问题。本文介绍了一种新颖的混合量子-经典深度学习模型，用于药物发现中的结合亲和力预测。",
    "tldr": "提出了一种用于药物发现的混合量子-经典融合神经网络模型，通过优化的量子架构将3D和空间图卷积神经网络相互整合，提高了结合亲和力预测的准确性。"
}